High HNRNPA3 expression is associated with lymph node metastasis and poor prognosis in patients treated with radical cystectomy.

CONCLUSION: HNRNPA3 may be a new biomarker to predict biologically aggressive cancers and determine the appropriate treatment modality in patients after radical cystectomy.
PMID: 33160845 [PubMed - as supplied by publisher]

Source: Urologic Oncology - November 4, 2020 Category: Urology & Nephrology Authors: Amano N, Matsumoto K, Shimizu Y, Nakamura M, Tsumura H, Ishii D, Sato Y, Iwamura M Tags: Urol Oncol Source Type: research